Several studies have shown that when tumor cells undergo EMT, Foxp3 reprograms T cell metabolism by suppressing glycolysis, enhancing OXPHOS, and increasing nicotinamide adenine dinucleotide (NAD) oxidation [162,163]. The gene discussed is FOXP3; the disease is neoplasm.